Ardelyx Inc (ARDX) Stock Price, Quote & News

Company Profile

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in Ju...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 745 1700

Website: www.ardelyx.com

Address:

400 Fifth Avenue, Suite 210, Waltham, United States

FerreroRocher Aug. 25 at 12:07 PM

$ARDX https://ir.ardelyx.com/news-releases/news-release-details/ardelyx-participate-upcoming-investor-conferences-1

3 · Reply

opportoni Aug. 25 at 12:03 PM

$ARDX Busy days in early September.

1 · Reply

TonyStar Aug. 25 at 4:57 AM

$ARDX Tomorrow judge panel will be revealed (or 26th,there could be a 1 day delay) ,it is right now disclosed up to 22nd of September .

2 · Reply

ISEEITALLTHETIME Aug. 25 at 12:32 AM

$ARDX Raab was relentlessly selling stock every two weeks. That suddenly stopped in May and at the same time Mott bought another $2 million worth of company stock. The stock has been up in 11 of the past 14 tradings sessions and unchanged in 1. This tells me something is in the works behind the scenes.

1 · Reply

Robin8877 Aug. 24 at 3:59 PM

$ARDX Sold about ten percent to lock in profits, swing traded a few others profitably. Will buy back after I am through playing. Goal is a 17,000 profit by Halloween. Challenging myself. Wish me luck!

2 · Reply

Minister_Maud Aug. 24 at 12:58 AM

$ARDX something is brewing. Someone knows something. This is odd behavior for the known facts.

5 · Reply

opportoni Aug. 23 at 10:11 PM

$ARDX For whatever reasons, Raab‘s 10b5 plan seems to have ended. Imagine if he were to join Mott and us in the buyers‘ camp now. That could carry us a long way.

2 · Reply

UnoffensiveName Aug. 23 at 7:03 PM

$ARDX possibly the most limited synopsis ever posted

2 · Reply

Robin8877 Aug. 23 at 12:45 PM

$ARDX BLOCKED

1 · Reply

Howardm34 Aug. 23 at 12:38 PM

$ARDX Impressive 3 month run. I would think we are heading to at least a year end range of $8-$10 If the CMS bundle issues gets any resolution, $10-$12. Have a great weekend, I hate weekends when my stocks are running 😜

2 · Reply

Ardelyx: Improved Outlook For Ibsrela And Xphozah

Aug 4, 2025, 8:11 PM EDT - 20 days ago

Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:08 PM EDT - 20 days ago

Ardelyx Announces Changes to the Executive Leadership Team

Aug 4, 2025, 4:01 PM EDT - 20 days ago

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 21, 2025, 8:00 AM EDT - 5 weeks ago

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Jun 2, 2025, 4:05 PM EDT - 2 months ago

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

May 21, 2025, 8:00 AM EDT - 3 months ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

May 6, 2025, 8:01 AM EDT - 3 months ago

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

May 2, 2025, 10:07 AM EDT - 4 months ago

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

May 1, 2025, 10:06 PM EDT - 4 months ago

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:01 PM EDT - 4 months ago

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:00 AM EDT - 4 months ago

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Apr 24, 2025, 8:01 AM EDT - 4 months ago

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Apr 17, 2025, 8:00 AM EDT - 4 months ago

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 10, 2025, 4:02 PM EDT - 4 months ago

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Mar 31, 2025, 4:03 PM EDT - 5 months ago

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Mar 13, 2025, 8:02 AM EDT - 5 months ago

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Mar 1, 2025, 8:30 AM EST - 6 months ago

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

HTLD NTR

Feb 26, 2025, 7:00 AM EST - 6 months ago

Tenapanor Approved in China for Hyperphosphatemia

Feb 25, 2025, 4:15 PM EST - 6 months ago

Ardelyx to Participate in Upcoming Investor Conferences

Feb 24, 2025, 2:28 PM EST - 6 months ago

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

Feb 21, 2025, 4:21 PM EST - 6 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

GERN MRNA PSNL TEM

Feb 20, 2025, 2:32 PM EST - 6 months ago

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 7:30 AM EST - 6 months ago

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 19, 2025, 8:01 AM EST - 6 months ago

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Jan 30, 2025, 4:30 PM EST - 7 months ago

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Jan 13, 2025, 8:03 AM EST - 7 months ago

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Jan 6, 2025, 8:00 AM EST - 8 months ago

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 24, 2024, 6:36 AM EST - 9 months ago

Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It

Nov 20, 2024, 8:00 AM EST - 9 months ago

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 9:34 AM EST - 10 months ago

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 8, 2024, 12:31 PM EST - 10 months ago

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

Nov 5, 2024, 8:00 AM EST - 10 months ago

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

Oct 31, 2024, 11:20 PM EDT - 10 months ago

Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 4:02 PM EDT - 10 months ago

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

Oct 28, 2024, 4:05 PM EDT - 10 months ago

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting

Oct 22, 2024, 4:05 PM EDT - 10 months ago

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

Oct 17, 2024, 8:00 AM EDT - 11 months ago

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

FerreroRocher Aug. 25 at 12:07 PM

$ARDX https://ir.ardelyx.com/news-releases/news-release-details/ardelyx-participate-upcoming-investor-conferences-1

3 · Reply

opportoni Aug. 25 at 12:03 PM

$ARDX Busy days in early September.

1 · Reply

TonyStar Aug. 25 at 4:57 AM

$ARDX Tomorrow judge panel will be revealed (or 26th,there could be a 1 day delay) ,it is right now disclosed up to 22nd of September .

2 · Reply

ISEEITALLTHETIME Aug. 25 at 12:32 AM

1 · Reply

Robin8877 Aug. 24 at 3:59 PM

2 · Reply

Minister_Maud Aug. 24 at 12:58 AM

$ARDX something is brewing. Someone knows something. This is odd behavior for the known facts.

5 · Reply

opportoni Aug. 23 at 10:11 PM

$ARDX For whatever reasons, Raab‘s 10b5 plan seems to have ended. Imagine if he were to join Mott and us in the buyers‘ camp now. That could carry us a long way.

2 · Reply

UnoffensiveName Aug. 23 at 7:03 PM

$ARDX possibly the most limited synopsis ever posted

2 · Reply

Robin8877 Aug. 23 at 12:45 PM

$ARDX BLOCKED

1 · Reply

Howardm34 Aug. 23 at 12:38 PM

2 · Reply

FibDrifter Aug. 23 at 5:54 AM

$ARDX Ardelyx Inc has commercial products for kidney disease facing adoption and reimbursement challenges

2 · Reply

Shorthand Aug. 22 at 10:17 PM

$ARDX Mott just doubled up almost. Big baller

1 · Reply

clipper20 Aug. 22 at 9:42 PM

$ARDX great week ARDX!! As of 07/31/2025 still 26.2 Million shares short. Let’s get tha CMS taken care off. I know some shorts hedge but man they have more balls than me holding on to there shorts

0 · Reply

smallfish78 Aug. 22 at 9:37 PM

$ARDX Here’s to all the SHORTS that have been smoked since earnings.

0 · Reply

FerreroRocher Aug. 22 at 8:54 PM

$ARDX Great to close out the week above $6!

1 · Reply

NoamStocksy Aug. 22 at 8:42 PM

$ARDX whats with the massive red candle into close?

1 · Reply

FerreroRocher Aug. 22 at 8:00 PM

$ARDX Is it Monday yet?

1 · Reply

MedHS55 Aug. 22 at 7:58 PM

$ARDX nothing but bot trades 100 and <100 share trades

0 · Reply

FerreroRocher Aug. 22 at 7:17 PM

$ARDX

1 · Reply

TupacLive Aug. 22 at 6:52 PM

$ARDX Was finally able to sell all shares and get out.

8 · Reply

CaliEmpress Aug. 22 at 6:42 PM

Made profit with $ARDX twice 8 months apart, still hold a large position in $CDTX average $15 and $KTOS average $24.5. Now allow me to introduce you to the new member of my portfolio $CRMD with an average at $13.56 and still adding.

3 · Reply

Burning_Cash Aug. 22 at 4:54 PM

$ARDX Just returned from my holiday. Hope that won’t jinx it 😁 @opportoni:

2 · Reply

Market Cap	1.47B
Revenue (ttm)	333.62M
Net Income (ttm)	-39.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-11.73%
Debt to Equity Ratio	1.44

Volume	3,653,900
Avg Vol	4,447,270
Day's Range	N/A - N/A
Shares Out	240.98M
Stochastic %K	79%
Beta	0.68
Analysts	Strong Sell
Price Target	$11.18